J&J talks "disciplined" M&A

Multiple analysts pressed Johnson & Johnson (NYSE:JNJ) about the pharma's M&A strategy during Tuesday's 2Q15 earnings call. "We do feel that there are several significant opportunities, really across each one of our segments that offer potential for growth and that are consistent with the strategic outline," said Chairman and CEO Alex Gorsky during the call's Q&A session.

He added the pharma will be "disciplined" with its approach to M&A. ...